BioCity Nottingham, Pennyfoot Street, Nottingham, NG1 1GF
t: +44 (0) 115 8880 406f: +44 (0) 115 8229345

News Articles

A brave new world for supplementary protection certificates?

01 August 2012

Life Sciences Intellectual Property Review 2012
Authors: Mike Snodin and Michael Pears

This article appeared in the 2012 edition of Life Sciences Intellectual Property Review. It discusses the opinion of Advocate-General Verica Trstenjak in the case of Neurim Pharmaceuticals (C-130/11). Whilst agreeing that it would be very harsh upon Neurim if they were not awarded and SPC, Mike and Michael highlight possible undesired side-effects in implementing the particular "fix" proposed by the Advocate-General that would award an SPC to Neurim.

We have placed cookies on your device to help make this website better. You can click the link below to disable cookies, otherwise, we'll assume you're happy to continue
Close This Notice

Disable Cookies | 3rd Party Data Processors